Lisinopril
Classification
Pharmaceutical
Regulatory Status
US prescription drug labeling exists for the named active ingredient. This record is not a substitute for the current label.
Sources
1
Review
n/a
Overview
Lisinopril is a labeled angiotensin-converting enzyme inhibitor. This record does not restate who should use it or a dose.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Benefits
The DailyMed Zestril label describes lisinopril for labeled hypertension, heart-failure, and post-myocardial-infarction uses.
Interactions & cautions
Flagged in source data
Drug interactions
potassium-raising medicines — Potassium supplements and potassium-sparing diuretics can add to hyperkalemia risk. The current label defines the caution. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw